Regeneron inks drug price deal

President Trump announced a landmark deal with Regeneron in the Oval Office, touting it as the 'biggest price reduction in history.' The agreement includes significant discounts on high-cost medications and a commitment to provide a life-changing hearing restoration therapy at no cost.

This move is part of a broader administration push to lower drug prices ahead of the midterm elections.

While the deal has been praised for providing immediate relief to patients, some industry experts are questioning the long-term impact on pharmaceutical innovation and the precedent of government-pressured price cuts.